It'll be fine everyone, relax, these meetings are taking place all the time, MSB has been no more or less asked the types of questions any biopharma would be. Some company's have pages upon pages, upon pages of questions to answer, MSB is actually looking pretty modest. MSB in EVERY area, will have anticipated the questions to be asked and have the smartest brains available to answer every question.
A lot of candidates with side-effects etc get passed no-worries, because they address real needs - like Remestemcel-L will in aGVHD.
Just My Views | DYOR | zzzzzzz well!
Ann: Trading Halt, page-36
-
- There are more pages in this discussion • 168 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |